Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome

Journal of Neuroscience Research

Volumn 90, Issue 1, 2012, Pages 122-131

  Nowicki, Marcin ^a   Kosacka, Joanna ^a   Serke, Heike ^a   Blüher, Matthias ^a,b   Spanel Borowski, Katharina ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Endoneural microvessels; Obese mouse models; Peripheral diabetic neuropathy; Sciatic nerve

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; LAMININ; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENDONEURIUM; FEMALE; MALE; METABOLIC SYNDROME X; MOUSE; MYELIN SHEATH; NERVE FIBER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; SCIATIC NERVE; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD36; BASEMENT MEMBRANE; BODY WEIGHT; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; LAMININ; LEPTIN; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVESSELS; MYELIN SHEATH; OBESITY; OXIDATIVE STRESS; RECEPTORS, LEPTIN; SCAVENGER RECEPTORS, CLASS E; SCHWANN CELLS; SCIATIC NERVE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TOLL-LIKE RECEPTOR 4; VON WILLEBRAND FACTOR;

EID: 81255168206     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22728     Document Type: Article

References (34)

1. Bartels ED, Bang CA, Nielsen LB. 2009. Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes. Eur J Clin Invest 39: 190-198.
2. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA. 2002. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats. Diabetes Metab Res Rev 18: 49-56.
3. Curtiss LK, Tobias PS. 2009. Emerging role of toll-like receptors in atherosclerosis. J Lipid Res Suppl S340-S345.
4. Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova I. 2006. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55: 3335-3343.
5. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker HJ, Ponnambalam S. 2008. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409: 349-355.
6. Estrella JS, Nelson RN, Sturges BK, Vernau KM, Williams DC, Le Couteur RA, Shelton GD, Mizisin AP. 2008. Endoneurial microvascular pathology in feline diabetic neuropathy. Microvasc Res 75: 403-410.
7. Goncalves AC, Tank J, Diedrich A, Hilzendeger A, Plehm R, Bader M, Luft FC, Jordan J, Gross V. 2009. Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension 53: 387-392.
8. Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, Chen M, Stannard B, Dietz KR, Le Roith D, Reitman ML. 2004. Genetic background (C57BL/6J vs. FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145: 3258-3264.
9. Hasegawa T, Kosaki A, Shimizu K, Matsubara H, Mori Y, Masaki H, Toyoda N, Inoue-Shibata M, Nishikawa M, Iwasaka T. 2006. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Exp Neurol 199: 274-280.
10. Hodgkinson CP, Laxton RC, Patel K, Ye S. 2008. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol 28: 2275-2281.
11. Holvoet P. 2008. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 70: 193-219.
12. Jin MS, Lee JO. 2008. Structures of the toll-like receptor family and its ligand complexes. Immunity 29: 182-191.
13. Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A. 2007. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb 14: 78-85.
14. Knudson JD, Payne GA, Borbouse L, Tune J. 2008. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep 10: 434-439.
15. Korda M, Kubant R, Patton S, Malinski T. 2008. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 295: H1514-H1521.
16. Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, Sharma AK, Boulton AJ, King RH, Thomas PK, Ward JD. 2005. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48: 578-585.
17. Mehta JL, Li D. 2002. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 39: 1429-1435.
18. Norido F, Canella R, Zanoni R, Gorio A. 1984. Development of diabetic neuropathy in the C57BL/ks (db/db) mouse and its treatment with gangliosides. Exp Neurol 83: 221-232.
19. Nowicki M, Müller K, Serke H, Kosacka J, Vilser C, Ricken A, Spanel-Borowski K. 2010. Oxidized low-density lipoprotein (oxLDL)-induced cell death in dorsal root ganglion cell cultures depends not on the lectin-like oxLDL receptor-1 but on the toll-like receptor-4. J Neurosci Res 88: 403-412.
20. Reid B, Martinov VN, Nja A, Lomo T, Bewick GS. 2003. Activity-dependent plasticity of transmitter release from nerve terminals in rat fast and slow muscles. J Neurosci 23: 9340-9348.
21. Reue K, Xu P, Wang XP, Slavin BG. 2000. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J Lipid Res 41: 1067-1076.
22. Said G. 2007. Diabetic neuropathy-a review. Nat Clin Pract Neurol 3: 331-340.
23. Shi Q, Hubbard GB, Kushwaha RS, Rainwater D, Thomas CA, Leland MM, Vandeberg JL, Wang XL. 2007. Endothelial senescence after high-cholesterol, high-fat diet challenge in baboons. Am J Physiol Heart Circ Physiol 292: H2913-H2920.
24. Singleton JR, Smith AG. 2006. Therapy insight: neurological complications of prediabetes. Nat Clin Pract Neurol 2: 276-282.
25. Somasekhar T, Nordlander RH, Reiser PJ. 1996. Alterations in neuromuscular junction morphology during fast-to-slow transformation of rabbit skeletal muscles. J Neurocytol 25: 315-331.
26. Tang SC, Lathia JD, Selvaraj PK, Jo DG, Mughal MR, Cheng A, Siler DA, Markesbery WR, Arumugam TV, Mattson MP. 2008. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol 213: 114-121.
27. Van Gaal LF, Mertens IL, De Block CE. 2006. Mechanisms linking obesity with cardiovascular disease. Nature 444: 875-880.
28. Verheijen MH, Chrast R, Burrola P, Lemke G. 2003. Local regulation of fat metabolism in peripheral nerves. Genes Dev 17: 2450-2464.
29. Warmington SA, Tolan R, McBennett S. 2000. Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse. Int J Obes Rel Metab Disord 24: 1040-1105.
30. Weibel ER. 1963. Principles and methods for the morphometric study of the lung and other organs. Lab Invest 12: 131-155.
31. Wisse BE, Kim F, Schwartz WM. 2007. Physiology. An integrative view of obesity. Science 318: 928-929.
32. Wong FS, Wen L. 2008. Toll-like receptors and diabetes. Ann N Y Acad Sci 1150: 123-132.
33. Wright DE, Johnson MS, Arnett MG, Smittkamp SE, Ryals JM. 2007. Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor null mutant (db/db) mice. J Peripher Nerv Syst 12: 250-261.
34. Zhang Y, He X, Chen X, Ma H, Liu D, Luo J, Du Z, Jin Y, Xiong Y, He J, Fang D, Wang K, Lawson WE, Hui JC, Zheng Z, Wu G. 2007. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterinemic pigs. Circulation 116: 526-534.